Clinical trial

NearWave Optical Molecular Monitoring

NCT06744465

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DEVICE · Unmapped registry intervention NearWave monitoring Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

NearWave Optical Molecular Monitoring

Design: INTERVENTIONAL · Status: RECRUITING · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2025-03-07

PhaseNA

Conditions

Breast Cancerverified · MONDO: breast cancer

HER2-positive Breast Cancercandidate · MONDO: HER2 positive breast carcinoma

TNBC - Triple-Negative Breast Cancerunresolved

HER2-negative Breast Cancerunresolved

Invasive Breast Carcinomaverified · MONDO: invasive breast carcinoma

Interventions

NearWave monitoringDEVICE

Sponsors & collaborators

Indiana Universitylead sponsor

University of Notre Damecollaborator

Elevate Venturescollaborator

NearWave Corp.collaborator

Mapped research locations

IndianapolisIndiana, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06744465 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.